Guest Column: Medicare doesn't want to pay for people with Alzheimer's
Medicare recently announced it will effectively refuse to cover Aduhelm, the first FDA-approved Alzheimer's disease treatment in two decades.
Medicare recently announced it will effectively refuse to cover Aduhelm, the first FDA-approved Alzheimer's disease treatment in two decades.